QPS Assay Finder
VALIDATED ASSAYS QPS
The vast majority of today’s modern bioanalytical methods for pharmacokinetics, pharmacodynamics, and immunogenicity assessment are based on mass spectrometry and/or immuno bioanalytical approaches. However, for a small but important number of compounds, LC MS/MS or LBA are less than satisfactory. A good alternative is Inductively Coupled Plasma Mass Spectrometry (ICP-MS). In ICP MS, the samples are ionized by an inductively coupled plasma (ionization source) and the ions of interest are separated, detected, and quantitated by a mass spectrometer.
The QPS Assay Finder contains a broad range of validated assays for all of your bioanalytical needs.
SEARCH FOR AN ASSAY HERE!
Found 835 Results
Duloxetine (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.5 – 200 ng/mL |
| Sample Volume: | 0.25 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Analgesic |
| Classification: | Drug Assays |
Dutasteride (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.05 – 50 ng/mL |
| Sample Volume: | 0.15 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Men’s Health |
| Classification: | Drug Assays |
Dutasteride (Matrix: Human Serum)
| Matrix: | Human Serum |
| Assay Range: | 0.05 – 50 ng/mL |
| Sample Volume: | 0.15 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Men’s Health |
| Classification: | Drug Assays |
Dutasteride (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 100 – 7500 pg/mL |
| Sample Volume: | 0.3mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Men’s Health |
| Classification: | Drug Assays |
E-selectin (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.6 – 3,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -70 |
| Platform: | ELISA |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
E-selectin (Matrix: Human Serum)
| Matrix: | Human Serum |
| Assay Range: | 0.6 – 3,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -70 |
| Platform: | ELISA |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
E-Selectin (rs5361) Genotyping (Matrix: Human Whole Blood)
| Matrix: | Human Whole Blood |
| Assay Range: | N.Ap. |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -80 |
| Platform: | TaqMan; QuantStudio |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Genomic Biomarkers |
Efavirenz (EFV) (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 1 – 1,500 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Antiviral – HIV |
| Classification: | Drug Assays |
Efavirenz (EFV) (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 5 – 5,000 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Antiviral – HIV |
| Classification: | Drug Assays |
Efavirenz (EFV) (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 15 – 6,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antiviral – HIV |
| Classification: | Drug Assays |
Empagliflozin (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 2 – 800 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Endocrinology |
| Classification: | Drug Assays |
Emtricitabine (FTC) (Matrix: Human Urine)
| Matrix: | Human Urine |
| Assay Range: | 0.5 – 100 ug/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Antiviral – HIV |
| Classification: | Drug Assays |
Emtricitabine (FTC) Tenofovir (TFV) in presence of Lamivudine (3TC), Efavirenz (EFV), and Dolutegravir (DTG) (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 10 – 4,000 ng/mL2.5 – 1,000 ng/mL |
| Sample Volume: | 0.3 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antiviral – HIV |
| Classification: | Drug Assays |
Emtricitabine (FTC)
Tenofovir (TFV) (Matrix: Human Plasma)
Tenofovir (TFV) (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 5 – 3,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Antiviral – HIV |
| Classification: | Drug Assays |
Enalapril
Enalaprilate (Matrix: Human Plasma)
Enalaprilate (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.500 – 50.0 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Enoxaparin Sodium (anti-Factor IIa) (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 1.0 – 8.0 µg/mL |
| Sample Volume: | 0.025 mL |
| Anti-Coagulant: | Citrate |
| Storage Temperature (°C): | -70 |
| Platform: | Activity / Colorimetric |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Enoxaparin Sodium (anti-Factor Xa) (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 1.0 – 10.0 µg/mL |
| Sample Volume: | 0.025 mL |
| Anti-Coagulant: | Citrate |
| Storage Temperature (°C): | -70 |
| Platform: | Activity / Colorimetric |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Entecavir (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 50 – 20,000 pg/mL |
| Sample Volume: | 0.5 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antiviral – HBV |
| Classification: | Drug Assays |
Erlotinib (Matrix: Human plasma)
| Matrix: | Human plasma |
| Assay Range: | 5 – 2500 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drug Assays |
Erlotinib (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 7.5 – 3,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drug Assays |
Erythromycin (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.100 – 100 ng/mL |
| Sample Volume: | 0.25 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Antibiotic |
| Classification: | Drug Assays |
Erythromycin (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 15 – 8,000 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antibiotic |
| Classification: | Drug Assays |
Erythromycin A (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 6 – 3,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antibiotic |
| Classification: | Drug Assays |
Erythromycin A (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 12 – 6,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antibiotic |
| Classification: | Drug Assays |
Escitalopram (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 1 – 50 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antidepressant |
| Classification: | Drug Assays |
DOWNLOAD THE FREE APPLE OR ANDROID APP HERE!
